Literature DB >> 19334394

[Community-acquired Pseudomonas stutzeri meningitis in an immunocompetent patient].

Mustafa Sünbül1, Muammer Zivalioğlu, Nuriye Taşdelen Fişgin.   

Abstract

Pseudomonas stutzeri which is an aerobic, non-fermentative gram-negative bacillus frequently found in soil, water and hospital environment, rarely leads to serious community-acquired infections. In this report a case of community-acquired meningitis due to P. stutzeri was presented. A 73-years-old male patient was admitted to the emergency department with the complaints of nausea, vomiting, headache, dizziness, difficulties in walking and speaking and loss of consciousness. There was no history of an underlying disease or immunosuppression. Physical examination revealed nuchal rigidity, however, Kernig and Brudzinski signs were negative. The cerebrospinal fluid (CSF) analysis revealed 0.4 mg/dl glucose (simultaneous blood glucose 145 mg/dl), and 618 mg/dl protein and 640 leucocyte/mm3 (90% PMNL). No bacteria were detected in Gram stained and Ehrlich-Ziehl-Neelsen stained CSF smears. Upon the diagnosis of acute bacterial meningitis, treatment with ceftriaxone and ampicillin was initiated, however, the patient died after 16 hours of hospitalization. CSF culture yielded the growth of gram-negative oxidase-positive bacteria and the isolate was identified as P. stutzeri by Vitek-2 Compact system (bioMerieux, France). The isolate was found to be sensitive to piperacillin/tazobactam, amikacin, gentamycin, ceftazidime, cefepime, ciprofloxacin, imipenem and meropenem. Since the patient was lost due to acute respiratory and cardiac failure, it was not possible to change the therapy to agent specific therapy. In conclusion, it should always be kept in mind that uncommon agents could lead to community-acquired meningitis in elderly patients and empirical treatment protocols might fail in such cases resulting in high morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19334394

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  3 in total

1.  Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease.

Authors:  Brigid S Boland; Parambir S Dulai; Michael Chang; William J Sandborn; Barrett G Levesque
Journal:  Am J Gastroenterol       Date:  2015-11       Impact factor: 10.864

2.  Infective endocarditis caused by Pseudomonas stutzeri in a patient with Marfan syndrome: Case report and brief literature review.

Authors:  Ahmad Shalabi; Tristan Ehrlich; Hans-Joachim Schäfers; Sören L Becker
Journal:  IDCases       Date:  2017-08-02

3.  Emergence and Genetic Characterization of Plasmid-Encoded VIM-2-Producing Pseudomonas stutzeri with Novel Integron In1998 Isolated from Cerebrospinal Fluid.

Authors:  Shuxiu Liu; Hao Xu; Xiaobing Guo; Shuang Li; Qian Wang; Yuan Li; Ruishan Liu; Jianjun Gou
Journal:  Infect Drug Resist       Date:  2021-08-24       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.